Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Int J Cancer
    August 2025
  1. MA S, Zhang Y, Xie S, Li X, et al
    Balanced diet quality and risk of upper gastrointestinal cancers: Insights from a prospective cohort study in China.
    Int J Cancer. 2025;157:658-671.
    >> Share

    July 2025
  2. LIU Y, Xue Q, Wang B, Ding X, et al
    Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer.
    Int J Cancer. 2025 Jul 2. doi: 10.1002/ijc.35511.
    >> Share

    June 2025
  3. GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al
    Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
    Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491.
    >> Share

  4. CHAN WC, Millwood I, Kartsonaki C, Du H, et al
    Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of 0.5 million Chinese adults.
    Int J Cancer. 2025;156:2094-2106.
    >> Share

    May 2025
  5. PELC Z, Sedlak K, Mlak R, Endo Y, et al
    Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysis.
    Int J Cancer. 2025 May 28. doi: 10.1002/ijc.35489.
    >> Share

    March 2025
  6. JIANG XW, Zhang L, Liu ZC, Zhou T, et al
    Integrative metabolomics and microbiomics analysis reveals distinctive microbiota-metabolites interactions in gastric carcinogenesis.
    Int J Cancer. 2025 Mar 10. doi: 10.1002/ijc.35392.
    >> Share

  7. ENGLISH KA, Goldsworthy M, Willis B, Kooblall KG, et al
    Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms.
    Int J Cancer. 2025;156:980-992.
    >> Share

    January 2025
  8. SLOTMAN E, Pape M, van Laarhoven HWM, Pouw RE, et al
    Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.
    Int J Cancer. 2025 Jan 9. doi: 10.1002/ijc.35314.
    >> Share

    December 2024
  9. SEWASTJANOW-SILVA M, Kwiatkowski E, Yamashita K, Abdelhakeem A, et al
    Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.
    Int J Cancer. 2024;155:2277-2286.
    >> Share

  10. INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al
    One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study.
    Int J Cancer. 2024;155:1944-1957.
    >> Share

    October 2024
  11. YAN X, Zeng H, Li H, Cao M, et al
    The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population-based cohort study.
    Int J Cancer. 2024;155:1203-1211.
    >> Share

    August 2024
  12. LIU J, Gan T, Hu W, Li Y, et al
    Does ambient particulate matter 1 increase the risk of gastric cancer in the northwest of China?
    Int J Cancer. 2024 Aug 23. doi: 10.1002/ijc.35144.
    >> Share

    July 2024
  13. WANG R, Chen XZ
    Comment on "Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study".
    Int J Cancer. 2024;155:184-185.
    >> Share

    June 2024
  14. MASETTI M, Al-Batran SE, Goetze TO, Thuss-Patience P, et al
    Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
    Int J Cancer. 2024;154:2142-2150.
    >> Share

  15. NAGEL G, Chen J, Jaensch A, Skodda L, et al
    Long-term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project.
    Int J Cancer. 2024;154:1900-1910.
    >> Share

    May 2024
  16. GONZALEZ-PALACIOS S, Compan-Gabucio LM, Torres-Collado L, Oncina-Canovas A, et al
    The protective effect of dietary folate intake on gastric cancer is modified by alcohol consumption: A pooled analysis of the StoP Consortium.
    Int J Cancer. 2024 May 16. doi: 10.1002/ijc.35004.
    >> Share

    December 2023
  17. SASAHARA M, Kanda M, Tanaka C, Shimizu D, et al
    Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis.
    Int J Cancer. 2023 Dec 27. doi: 10.1002/ijc.34831.
    >> Share

  18. ZHANG Q, Zhou Y, Song L, Fang W, et al
    China special issue on gastrointestinal tumors-Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study.
    Int J Cancer. 2023;153:1885-1893.
    >> Share

    November 2023
  19. GOETZE TO, Stein A, Lorenzen S, Habibzada T, et al
    Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy.
    Int J Cancer. 2023;153:1726-1733.
    >> Share

  20. RIJKEN A, Pape M, Simkens GA, de Hingh IHJT, et al
    Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Int J Cancer. 2023 Nov 2. doi: 10.1002/ijc.34780.
    >> Share

    October 2023
  21. FAN XH, Zhang Y, Wang P, Song QQ, et al
    A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening.
    Int J Cancer. 2023 Oct 16. doi: 10.1002/ijc.34739.
    >> Share

    September 2023
  22. LLACH J, Salces I, Guerra A, Penas B, et al
    Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy.
    Int J Cancer. 2023 Sep 7. doi: 10.1002/ijc.34714.
    >> Share

  23. PALOMAR-CROS A, Straif K, Romaguera D, Aragones N, et al
    Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain).
    Int J Cancer. 2023;153:979-993.
    >> Share

    August 2023
  24. CHENG L, Chang Y, Xia Z, Liu Y, et al
    Remote modulation of WWOX by an intronic variant associated with survival of Chinese gastric cancer patients.
    Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34703.
    >> Share

  25. CAO F, Sun H, Yang Z, Bai Y, et al
    Multiple approaches revealed MGc80-3 as a somatic hybrid with HeLa cells rather than a gastric cancer cell line.
    Int J Cancer. 2023 Aug 6. doi: 10.1002/ijc.34677.
    >> Share

    July 2023
  26. GOETZE TO, Hofheinz RD, Gaiser T, Schmalenberg H, et al
    Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
    Int J Cancer. 2023;153:153-163.
    >> Share

    March 2023
  27. GHASEMI-KEBRIA F, Semnani S, Fazel A, Etemadi A, et al
    Esophageal and gastric cancer incidence trends in Golestan, Iran: an age-period-cohort analysis 2004-2018.
    Int J Cancer. 2023 Mar 21. doi: 10.1002/ijc.34518.
    >> Share

  28. MOHRING C, Manczak A, Timotheou A, Sadeghlar F, et al
    Perioperative Therapy with Flot4 Significantly Increases Survival in Patients with Gastroesophageal and Gastric Cancer in A Large Real-World Cohort.
    Int J Cancer. 2023 Mar 15. doi: 10.1002/ijc.34511.
    >> Share

  29. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    >> Share

    February 2023
  30. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016